Edwards Lifesciences Corp
Edwards Lifesciences
EW · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $6.1B
- Assets
- $13.7B
- SEC filing
- DEF 14A
- Filed
- March 26, 2026
Executive Compensation
Compensation reported for Edwards Lifesciences’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Mr. Zovighian
Chief Executive Officer And Director
$17.5M
Reported total
- Salary
- $1,192,500
- Stock awards
- $7,167,024
- Incentives
- $2,406,537
- Option awards
- $6,499,109
- Other
- $189,085
Mr. Ullem
Corporate Vice President, Chief Financial Officer
$6.1M
Reported total
- Salary
- $807,898
- Stock awards
- $2,205,238
- Incentives
- $966,435
- Option awards
- $1,999,726
- Other
- $71,257
Mr. Wood
Former Corporate Vice President And Group President, Transcatheter Aortic Valve Replacement And Surgical Structural Heart
$4.9M
Reported total
- Salary
- $635,919
- Stock awards
- $1,818,499
- Incentives
- $689,382
- Option awards
- $1,648,710
- Other
- $61,829
Mr. Chopra
Corporate Vice President, Transcatheter Mitral And Tricuspid Therapies
$4.7M
Reported total
- Salary
- $671,042
- Stock awards
- $1,764,066
- Incentives
- $824,239
- Option awards
- $1,375,784
- Other
- $60,611
Mr. Bobo
Corporate Vice President, Strategy & Corporate Development
$4.2M
Reported total
- Salary
- $759,783
- Stock awards
- $1,378,274
- Incentives
- $786,899
- Option awards
- $1,249,829
- Other
- $48,580
Ms. Brüls
$3.7M
Reported total
- Salary
- $726,586
- Stock awards
- $1,020,334
- Incentives
- $719,581
- Option awards
- $924,995
- Other
- $340,611
Mr. Zovighian
Chief Executive Officer And Director
$17.5M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 26, 2026.
- Salary
- $1.2M
- Stock Awards
- $7.2M
- Option Awards
- $6.5M
- Incentives
- $2.4M
- Other
- $189K
Historical Compensation
Mr. Zovighian total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,192,500 | $7,167,024 | $17,454,255 |
| 2024 | $1,133,846 | $6,147,250 | $14,579,474 |
| 2023 | $972,814 | $5,099,085 | $12,869,020 |
Named Executive Officers
Mr. Zovighian
Chief Executive Officer And Director
Edwards Lifesciences · EW
$17.5M
FY 2025 · DEF 14A
Mr. Ullem
Corporate Vice President, Chief Financial Officer
Edwards Lifesciences · EW
$6.1M
FY 2025 · DEF 14A
Mr. Bobo
Corporate Vice President, Strategy & Corporate Development
Edwards Lifesciences · EW
$4.2M
FY 2025 · DEF 14A
Ms. Brüls
Edwards Lifesciences · EW
$3.7M
FY 2025 · DEF 14A
Mr. Chopra
Corporate Vice President, Transcatheter Mitral And Tricuspid Therapies
Edwards Lifesciences · EW
$4.7M
FY 2025 · DEF 14A
Mr. Wood
Former Corporate Vice President And Group President, Transcatheter Aortic Valve Replacement And Surgical Structural Heart
Edwards Lifesciences · EW
$4.9M
FY 2025 · DEF 14A
Source information
- Company
- Edwards Lifesciences Corp
- Ticker
- EW · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 26, 2026
- SEC accession number
- 0001099800-26-000015
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →